131 related articles for article (PubMed ID: 23783647)
21. Human papillomavirus-associated subsequent malignancies among long-term survivors of pediatric and young adult cancers.
Ojha RP; Tota JE; Offutt-Powell TN; Klosky JL; Minniear TD; Jackson BE; Gurney JG
PLoS One; 2013; 8(8):e70349. PubMed ID: 23940566
[TBL] [Abstract][Full Text] [Related]
22. Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis-United States, 2003.
Ekwueme DU; Chesson HW; Zhang KB; Balamurugan A
Cancer; 2008 Nov; 113(10 Suppl):2936-45. PubMed ID: 18980277
[TBL] [Abstract][Full Text] [Related]
23. Examining the association between socioeconomic status and potential human papillomavirus-associated cancers.
Benard VB; Johnson CJ; Thompson TD; Roland KB; Lai SM; Cokkinides V; Tangka F; Hawkins NA; Lawson H; Weir HK
Cancer; 2008 Nov; 113(10 Suppl):2910-8. PubMed ID: 18980274
[TBL] [Abstract][Full Text] [Related]
24. Human Papillomavirus-Associated Cancers - United States, 2008-2012.
Viens LJ; Henley SJ; Watson M; Markowitz LE; Thomas CC; Thompson TD; Razzaghi H; Saraiya M
MMWR Morb Mortal Wkly Rep; 2016 Jul; 65(26):661-6. PubMed ID: 27387669
[TBL] [Abstract][Full Text] [Related]
25. European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women?
Malvezzi M; Bertuccio P; Rosso T; Rota M; Levi F; La Vecchia C; Negri E
Ann Oncol; 2015 Apr; 26(4):779-786. PubMed ID: 25623049
[TBL] [Abstract][Full Text] [Related]
26. Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods.
Watson M; Saraiya M; Ahmed F; Cardinez CJ; Reichman ME; Weir HK; Richards TB
Cancer; 2008 Nov; 113(10 Suppl):2841-54. PubMed ID: 18980203
[TBL] [Abstract][Full Text] [Related]
27. Thyroid Cancer Epidemiology in South Spain: a population-based time trend study.
Salamanca-Fernández E; Rodriguez-Barranco M; Chang-Chan YL; Redondo-Sánchez D; Domínguez-López S; Bayo E; Narankiewicz D; Expósito J; Sánchez MJ
Endocrine; 2018 Nov; 62(2):423-431. PubMed ID: 30043094
[TBL] [Abstract][Full Text] [Related]
28. Annual Report to the Nation on the Status of Cancer, Featuring Cancer in Men and Women Age 20-49 Years.
Ward EM; Sherman RL; Henley SJ; Jemal A; Siegel DA; Feuer EJ; Firth AU; Kohler BA; Scott S; Ma J; Anderson RN; Benard V; Cronin KA
J Natl Cancer Inst; 2019 Dec; 111(12):1279-1297. PubMed ID: 31145458
[TBL] [Abstract][Full Text] [Related]
29. Rural-Urban Differences in Human Papillomavirus-associated Cancer Trends and Rates.
Zahnd WE; Rodriguez C; Jenkins WD
J Rural Health; 2019 Mar; 35(2):208-215. PubMed ID: 29808500
[TBL] [Abstract][Full Text] [Related]
30. PANCREATIC CANCER IN BRAZIL: MORTALITY TRENDS AND PROJECTIONS UNTIL 2029.
Barbosa IR; Santos CAD; Souza DLB
Arq Gastroenterol; 2018; 55(3):230-236. PubMed ID: 30540083
[TBL] [Abstract][Full Text] [Related]
31. Epidemiological and economic burden of potentially HPV-related cancers in France.
Abramowitz L; Lacau Saint Guily J; Moyal-Barracco M; Bergeron C; Borne H; Dahlab A; Bresse X; Uhart M; Cancalon C; Catella L; Bénard S
PLoS One; 2018; 13(9):e0202564. PubMed ID: 30235216
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA
Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625
[TBL] [Abstract][Full Text] [Related]
33. The evolution of HPV-related anogenital cancers reported in Quebec - incidence rates and survival probabilities.
Louchini R; Goggin P; Steben M
Chronic Dis Can; 2008; 28(3):99-106. PubMed ID: 18341764
[TBL] [Abstract][Full Text] [Related]
34. Predicted incidence of oral cavity, oropharyngeal, laryngeal, and hypopharyngeal cancer in Spain and implications for cancer control.
de Souza DL; Pérez MM; Curado MP
Cancer Epidemiol; 2011 Dec; 35(6):510-4. PubMed ID: 21470934
[TBL] [Abstract][Full Text] [Related]
35. Update of HPV-associated female genital cancers in the United States, 1999-2004.
Watson M; Saraiya M; Wu X
J Womens Health (Larchmt); 2009 Nov; 18(11):1731-8. PubMed ID: 19951205
[TBL] [Abstract][Full Text] [Related]
36. Economic burden of non-cervical cancers attributable to human papillomavirus: a European scoping review.
Préaud E; Largeron N
J Med Econ; 2013; 16(6):763-76. PubMed ID: 23565814
[TBL] [Abstract][Full Text] [Related]
37. Cancer mortality in Europe in 2015 and an overview of trends since 1990.
Bertuccio P; Alicandro G; Malvezzi M; Carioli G; Boffetta P; Levi F; La Vecchia C; Negri E
Ann Oncol; 2019 Aug; 30(8):1356-1369. PubMed ID: 31147719
[TBL] [Abstract][Full Text] [Related]
38. Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea.
Choi I; Lee D; Son KB; Bae S
BMC Public Health; 2020 Jun; 20(1):1035. PubMed ID: 32600300
[TBL] [Abstract][Full Text] [Related]
39. Long-term trends in pancreatic cancer mortality in Spain (1952-2012).
Seoane-Mato D; Nuñez O; Fernández-de-Larrea N; Pérez-Gómez B; Pollán M; López-Abente G; Aragonés N
BMC Cancer; 2018 Jun; 18(1):625. PubMed ID: 29866063
[TBL] [Abstract][Full Text] [Related]
40. Incremental healthcare resource utilization and costs for patients with cervical, vaginal, vulvar, anal, and oropharyngeal cancer in the United States.
Prabhu V; Kathe N; Saxena K; Walia A; Markan R; Myers E; Einstein M
Curr Med Res Opin; 2021 Sep; 37(9):1599-1607. PubMed ID: 34018457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
